New drug trial to investigate treatment for patients with bronchiectasis
200,000 people in the UK have what is considered a ‘hidden’ lung condition
Read More
Author: PharmaTimes
SynaptixBio awarded £2m BioMedical Catalyst grant from Innovate UK
The grant will support clinical trials of rare disease therapy for leukodystrophy
Read More
AMR testing technology from QuantaMatrix backed by research paper in Nature
The new test takes an average of 13 hours to identify the correct treatment compared to several days with current methods
Read More
GOSH and Oliver Patch in cancer research partnership with Innovative Trials
Globally 400,000 children are impacted every year by cancers that include leukaemia and lymphoma
Read More
Theramex’s Eladynos recommended by NICE for post-menopausal bone disease
Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
